Scenarios that move AVTR
Avantor, Inc. Common Stock
Scenarios that move AVTR: 7 analyses, 5 positive, 2 negative.
- · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▲ · impact +6 · confidence low · horizon quarters
- · SRX Global SPV agrees to acquire CERo Therapeutics — ▲ · impact +4 · confidence low · horizon quarters
- · Vaxcyte prices concurrent stock, warrant and convertible note offerings — ▲ · impact +8 · confidence low · horizon quarters
- · Genmab and AbbVie report positive epcoritamab lymphoma trial results — ▲ · impact +10 · confidence low · horizon quarters
- · ADARx Pharmaceuticals prices upsized $446.3 million initial public offering — ▲ · impact +7 · confidence low · horizon quarters
- · Sion cuts workforce nearly half after CF study failure — ▼ · impact -12 · confidence low · horizon quarters
- · Cooper Companies faces scrutiny as US channel inventories decline — ▼ · impact -8 · confidence low · horizon quarters